RAIN — Rain Oncology Balance Sheet
0.000.00%
HealthcareMicro Cap
- $44.03m
 - -$33.29m
 
Annual balance sheet for Rain Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st  | 2020 December 31st  | 2021 December 31st  | 2022 December 31st  | |
|---|---|---|---|---|
| Period Length: | — | — | — | — | 
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | 
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 5.79 | 58.9 | 140 | 130 | 
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 6.27 | 59.5 | 146 | 134 | 
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.692 | 0.546 | 0.551 | 0.351 | 
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 7.39 | 61.1 | 147 | 135 | 
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1.22 | 3.42 | 16.3 | 22 | 
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 4.5 | 3.8 | 16.6 | 22.1 | 
| Redeemable Preferred Stock | ||||
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 2.9 | 57.3 | 131 | 113 | 
| Total Liabilities & Shareholders' Equity | 7.39 | 61.1 | 147 | 135 | 
| Total Common Shares Outstanding |